Columnist Jennifer Lynne assesses the effects of Pfizer's decision to halt production of its hemophilia B gene therapy, Beqvez.
Pfizer said it will discontinue gene therapy Beqvez (fidanacogene elaparvovec-dzkt), an approved hemophilia B treatment.
The Loma Linda University Health (LLUH) Hemophilia Treatment Center has become the first clinic in California offering Hympavzi (marstacimab) for people with hemophilia B. “For the first time, ...
It's been several months since his sons have experienced complications of hemophilia, and columnist Joe MacDonald is grateful but anxious.
Every person with hemophilia is unique, especially with a complication like an inhibitor, columnist Cazandra Campos-MacDonald writes.
Hemophilia may impose some limitations, but it doesn't stop columnist G Shellye Horowitz from finding ways to fly through the ...
The first hemophilia B patient at the Loma Linda University Health Hemophilia Treatment Center to receive Hympavzi is a ...
Columnist Alliah Czarielle discusses the benefits — and potential risks — of several tools that can be useful in a hemophilia household.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback